TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Sarepta Therapeutics Inc (SRPT)

Healthcare Biotechnology
15.90 $
+6.9% vs. previous close
Closing price · As of: 3. Aug 2026

Sarepta Therapeutics Inc (SRPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 3,179 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet SRPT
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
3,126 3,110 3,265 3,224 3,424 3,600 3,963 3,465 3,680 3,493 3,350 3,179
2,473 2,451 2,579 2,465 2,684 2,685 3,073 2,433 2,657 2,722 2,538 2,310
852 542 428 427 384 198 1,103 241 511 613 801 464
1,861 1,734 1,676 1,391 1,460 1,198 1,355 523 800 851 940 653
267 354 437 419 392 516 650 725 610 542 520 548
227 244 323 374 486 566 750 941 994 1,077 915 1,001
18 20 30 29 28 28 27 26 31 30 29 31
2,384 2,345 2,405 2,263 2,347 2,379 2,435 2,323 2,322 2,173 2,209 1,674
499 451 654 609 688 699 732 606 920 921 1,095 499
327 322 123 106 92 92 13 – – 10 11 –
110 88 165 92 107 119 214 156 137 94 281 70
1,236 1,237 1,133 1,134 1,135 1,136 1,137 1,138 1,139 1,035 829 838
741 764 859 961 1,077 1,221 1,528 1,143 1,357 1,320 1,141 1,505
-4,451 -4,492 -4,446 -4,410 -4,404 -4,370 -4,211 -4,658 -4,462 -4,642 -4,877 -4,546
89 89 106 99 99 100 108 97 107 100 105 122

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?